ALLERGAN’s OCUFEN POST-OP CYSTOID MACULAR EDEMA DATA NEEDS MORE ANALYSIS OF DROPOUTS BEFORE APPROVAL, FDA OPHTHALMIC DRUGS SUBCOMMITTEE CONCLUDES OCT. 27